Sign in

CIK 0001979414

  • Emerging growth company

NEONC TECHNOLOGIES HOLDINGS, INC.

Sign in to watch
Ticker
NTHI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
921954864
Phone
+1 310-663-7831
Business address
23975 PARK SORRENTO, SUITE 205, CALABASAS, CA, 91302
  1. 4/A Open-market sale CEO sold 39,233 shares at an average $24.85 ($975,055)
  2. 4 Open-market buy President bought 2,000 shares at $7.39 ($14,785)
  3. 4 Open-market buy CEO bought 5,468 shares at an average $7.32 ($40,002)
  4. 4 Open-market buy CFO bought 675 shares at $7.29 ($4,921)
  5. 4 Open-market buy CFO bought 135 shares at $7.23 ($976)
  6. 4/A Open-market buy CFO bought 90 shares at $7.01 ($631)
  7. 4 Open-market buy Director bought 5,100 shares at an average $7.31 ($37,258)
  8. 4 Open-market buy CFO bought 90 shares at $7.01 ($631)
  9. 4 Open-market buy CEO bought 400 shares at $7.00 ($2,800)
  10. 4 Open-market buy President bought 10,000 shares at an average $10.65 ($106,515)
  11. 4/A Open-market sale CFO sold 6,616 shares at an average $24.85 ($164,426)
  12. 4/A Open-market sale Director sold 38,464 shares at an average $24.85 ($955,941)
  13. 4/A Open-market sale COO sold 11,847 shares at an average $24.85 ($294,432)
  14. 4/A Open-market sale Director sold 57,696 shares at an average $24.85 ($1,433,912)
  15. 4/A Open-market sale CEO sold 39,233 shares at an average $24.85 ($975,055)
  16. 4 Grant or award Director acquired 50,000 shares (grant or award)
  17. 4 Other disposition CFO disposed of 687 shares (other)
  18. 4 Grant or award Director acquired 50,000 shares (grant or award)
  19. 4 Grant or award Director acquired 50,000 shares (grant or award)
  20. 4 Other disposition Director disposed of 3,996 shares (other)

Page 3 of 4 · 71 filings